Physicians Care Aspirin
NDC 0924-0105, Aspirin, tablet, film coated, from Acme United Corporation.
- Product NDC
- 0924-0105
- Status
- Listed
- Labeler
- Acme United Corporation
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M013
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0924-0105 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ASPIRIN325 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0924-0105-00 | 00924010500 | 2 TABLET, FILM COATED in 1 PACKET (0924-0105-00) |
| 0924-0105-01 | 00924010501 | 50 PACKET in 1 BOX (0924-0105-01) / 2 TABLET, FILM COATED in 1 PACKET |
| 0924-0105-02 | 00924010502 | 125 PACKET in 1 BOX (0924-0105-02) / 2 TABLET, FILM COATED in 1 PACKET |
| 0924-0105-03 | 00924010503 | 10 PACKET in 1 BOX (0924-0105-03) / 2 TABLET, FILM COATED in 1 PACKET |
| 0924-0105-04 | 00924010504 | 6 PACKET in 1 BOX (0924-0105-04) / 2 TABLET, FILM COATED in 1 PACKET (0924-0105-00) |
| 0924-0105-05 | 00924010505 | 20 PACKET in 1 BOX (0924-0105-05) / 2 TABLET, FILM COATED in 1 PACKET (0924-0105-00) |
| 0924-0105-06 | 00924010506 | 250 PACKET in 1 BOX (0924-0105-06) / 2 TABLET, FILM COATED in 1 PACKET (0924-0105-00) |
| 0924-0105-07 | 00924010507 | 25 PACKET in 1 BOX (0924-0105-07) / 2 TABLET, FILM COATED in 1 PACKET |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0924-0105 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0924-0105 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0924-0105. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.